Carbonylated proteins in BAL of patients with interstititial lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 344s Year: 2005
Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
BAL protein profiles specific of different interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Peroxidation processes, cytokines, BALF and blood cytology in patients with occupational lung diseases and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002
Levels of oxidised mitochondria in BAL macrophages in fibrotic ILDs. Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009
Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD) Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis Year: 2021
Upregulation of expression of membrane apoptosis signals by bronchoalveolar lavage cells in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
Circulating inflammatory proteins and red blood cells antioxidant activity in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 537s Year: 2003
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location Source: International Congress 2017 – ILDs: clinical problems Year: 2017
Proteomic analysis of antioxidant proteins in bronchoalveolar lavage of patients with pulmonary Langerhans-cell histiocytosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003
Antimicrobial peptides in bronchoalveolar lavage in patients with chronic lung diseases Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018
Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in lung fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016
Serum heat shock protein 47 levels in patients with drug induced lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012